Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A type of lupus erythematosus characterized by deep dermal or subcutaneous nodules, most often on the head, face, or upper arms. It is generally chronic and occurs most often in women between the ages of 20 and 45.
Biomarker and diagnostic research for lupus erythematosus panniculitis has been reported in the published literature.
No clinical trials have been registered for lupus erythematosus panniculitis.
53 publications have been identified in PubMed for lupus erythematosus panniculitis. Research spans Case Report / Case Series (64%), Review / Meta-Analysis (11%), and Other (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 34 | 64% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:07 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
6 |
11% |
Other research | 5 | 9% |
Testing and diagnosis research | 3 | 6% |
Laboratory research | 2 | 4% |
Clinical study results | 1 | 2% |
Disease patterns and progression | 1 | 2% |
New treatment approaches | 1 | 2% |
Adams MJ (2026). [PMID: 41714168](https://pubmed.ncbi.nlm.nih.gov/41714168/). *The Journal of dermatology*. [Clinical Trial Publication]
Housset M (2026). [PMID: 41872079](https://pubmed.ncbi.nlm.nih.gov/41872079/). *Eur J Dermatol*. [Case Report / Case Series]
Ameri M (2026). [PMID: 42086498](https://pubmed.ncbi.nlm.nih.gov/42086498/). *Allergy*. [Basic Science / Preclinical]
Koritala T (2026). [PMID: 29494121](https://pubmed.ncbi.nlm.nih.gov/29494121/). *Unknown Journal*. [Other]
Bai A (2026). [PMID: 42246355](https://pubmed.ncbi.nlm.nih.gov/42246355/). *Dermatol Online J*. [Case Report / Case Series]
Hou H (2026). [PMID: 41315880](https://pubmed.ncbi.nlm.nih.gov/41315880/). *Journal of cutaneous medicine and surgery*. [Review / Meta-Analysis]
Mohammed SR (2026). [PMID: 41716945](https://pubmed.ncbi.nlm.nih.gov/41716945/). *Case reports in rheumatology*. [Case Report / Case Series]
Sanchez-Diaz M (2026). [PMID: 41992569](https://pubmed.ncbi.nlm.nih.gov/41992569/). *Int J Dermatol*. [Other]
Sukumaran S (2026). [PMID: 29630197](https://pubmed.ncbi.nlm.nih.gov/29630197/). *Unknown Journal*. [Other]
Chiong T (2026). [PMID: 41642794](https://pubmed.ncbi.nlm.nih.gov/41642794/). *Clinical and experimental dermatology*. [Case Report / Case Series]
AI-curated news mentioning lupus erythematosus panniculitis
Updated Sep 8, 2026
A recent study characterizes myocarditis associated with systemic lupus erythematosus, highlighting its transition from a rare clinical manifestation to potential subclinical involvement. This research may inform future diagnostic and treatment strategies for affected patients.
A recent study published in PubMed highlights the occurrence of simultaneous calcified and noncalcified fibrotic splenic nodules in patients with systemic lupus erythematosus. This discovery may enhance understanding of splenic manifestations in this autoimmune disease.
A recent study highlights the diagnostic challenges associated with atypical facial and scalp lupus erythematosus tumidus, emphasizing long-term misdiagnosis and conflicting histopathological findings. This research underscores the need for improved diagnostic criteria in rare dermatological conditions.
Alumis' TYK2 inhibitor has failed in a pivotal study for lupus, joining other TYK2 blockers that have struggled outside of psoriasis and psoriatic arthritis. Despite this setback, Alumis remains optimistic about the drug's potential in lupus.